As of  November 2019 all 71 of New Jersey’s acute-care hospitals were connected to and sharing data with the statewide New Jersey Health Information Network (NJHIN), either directly or through their regional Healthcare Information Exchange …

A healthcare provider, health information network, health information exchange or a health IT developer can be an actor of information blocking. Information blocking is any activity that interferes with or limits access, exchange, or use …

Local municipalities and communities are addressing an unprecedented number of challenges due to unrest, conflict and anxiety created by the COVID-19 pandemic, political turmoil and economic slowdown. The impact of these current crises will persist …

Today’s advanced manufacturers are facing an escalating skills gap in their work force. For many, older employees are reaching retirement age in large numbers and there is a shortage of skilled employees to fill their shoes. Technical high schools and community …

The New Jersey Innovation Institute (NJII) has partnered in a Joint Venture with ViRvii, Inc., a proprietary Virtual Reality (VR) and Augmented Reality (AR) technology and platform provider to become the leader in professional workforce …

Like all businesses, U.S. based advanced manufacturers are facing a brave new world as a result of COVID -19.  Unanticipated disruption to their supply chains, workforce uncertainty and entirely new cost versus risk models are causing local manufacturers to re-think and re-assess their …

All 71 hospitals in New Jersey contribute information about patient admissions, discharges and transfers to the New Jersey Health Information Network (NJHIN). In the midst of the COVID-19 pandemic they all recognize the importance of …

The New Jersey Innovation Institute (NJII) has partnered with education technology provider Castle Point Learning Systems (CPLS) to expand the latter’s groundbreaking online mathematics learning platform, Gradarius™. Gradarius offers interactive, customizable instruction in all levels of mathematics, from basic math and …

The New Jersey Innovation Institute’s Biopharma Division, which includes BioCentriq, its cell and gene therapy development and manufacturing center, has welcomed Beth Thompson-Webb to its advisory committee.  Thompson-Webb has more than two decades of experience in life sciences …

Dr. Haro Hartounian is senior vice president and general manager of the Biopharma Division of the New Jersey Innovation Institute (NJII). The division, founded in 2015, includes a state-of-the-art cell and gene therapy development center …

NJII announces that qualification and validation of its clinical manufacturing facility for cell and gene therapies is underway, and the name of the center will be BioCentriq. May 4, 2020:  Newark, N.J. – Today the …

Earlier this week, New Jersey Innovation Institute CEO Simon Nynens spoke with the New Jersey Health Care Quality Institute (NJHCQI), a nonprofit coalition devoted to improving healthcare in the Garden State. His “Take Five Interview” …

Organizations of all sizes are going to work remotely – what’s your strategy? Before COVID-19 changed our world, virtual and distributed teams were in the process of becoming important work models in the tech world. …

April 20, 2020, Newark, NJ – New Jersey Innovation Institute’s (NJII) announced today that Jennifer D’Angelo will join NJII as a Vice President and General Manager, effective May 4th. She will lead the Healthcare division. …

The New Jersey Innovation Institute (NJII) has appointed Dr. Deirdre Letson-Christofalo as vice president of its Human Capital Division and Dan Kaminski as vice president and general manager of Data & Technology. Both units were …

Congrats to Kwame Sarfo for taking second place out of 35 competitors in the Rutgers Business Plan Competition last month. Sarfo successfully pitched a plan to expand the Original Kaneshie Market, a West African and …

The New Jersey Innovation Institute’s Biopharma Division welcomed Kevin D. Belfield to its advisory committee. The committee is made up of executives from leading pharmaceutical and biotech organizations, and Dr. Belfield — a renowned scientist …

April 6, 2020, Newark, NJ – Tomas Gregorio, the senior vice president and general manager of the New Jersey Innovation Institute’s (NJII) Healthcare Division announced today that he has accepted a newly created position as …